Financial Architects, Inc Ironwood Pharmaceuticals Inc Call Options Transaction History

Financial Architects, Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 03, 2019	SELL	$8.27 - $12.73 $12,405 - $19,095	-1,500 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$7.8 - $16.13 $11,700 - $24,195	-1,500 Reduced 50.0%	1,500 $16,000
Q3 2018 Oct 29, 2018	BUY	$14.31 - $17.65 $42,930 - $52,949	3,000 New	3,000 $56,000
Q2 2018 Aug 03, 2018	SELL	$11.83 - $16.2 $11,830 - $16,200	-1,000 Closed	0 $0
Q1 2018 Apr 23, 2018	BUY	$11.13 - $13.63 $11,130 - $13,630	1,000 New	1,000 $15,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.